APA (7th ed.) Citation

Akemi Egami, Shinji Takahashi, Takeshi Kokubo, Sreedevi Boggarapu, & Eric Beresford. (2023). Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Akemi Egami, Shinji Takahashi, Takeshi Kokubo, Sreedevi Boggarapu, and Eric Beresford. Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan. Adis, Springer Healthcare, 2023.

MLA (9th ed.) Citation

Akemi Egami, et al. Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan. Adis, Springer Healthcare, 2023.